Hadeel Delman Najim, Mohammed Mahmood Mohammed, and Abbas Mahdi Rahmah. 2024. “Influence of Adding Empagliflozin to Conventional Anti-Diabetic Therapy on Quality of Life Scale for Type 2 Diabetic Patients”. Iraqi Journal of Pharmaceutical Sciences 33 (3): 142-49. https://doi.org/10.31351/vol33iss3pp142-149.